Atara Biotherapeutics, Inc.

SUSQUEHANNA INTERNATIONAL GROUP, LLP ATRA

Report date

3/31/2024

Quarter

2024 Q1

Filed

5/7/2024

Shares

20,155

Value ($000)

14

Weight

0.0%

2019 Q4 - 2024 Q1 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q1	5/7/2024	14	0.0%	20,155	3/31/2024
2023 Q4	2/14/2024	45	0.0%	87,415	12/31/2023
2023 Q3	11/14/2023	316	0.0%	213,843	9/30/2023
2023 Q2	8/11/2023	253	0.0%	157,150	6/30/2023
2023 Q1	5/16/2023	643	0.0%	221,705	3/31/2023
2022 Q4	2/14/2023	187	0.0%	57,090	12/31/2022
2022 Q3	11/14/2022	854	0.0%	225,818	9/30/2022
2022 Q2	8/15/2022	458	0.0%	58,881	6/30/2022
2022 Q1	5/16/2022	1,089	0.0%	117,264	3/31/2022
2021 Q4	2/14/2022	2,000	0.0%	126,897	12/31/2021
2021 Q3	11/15/2021	1,857	0.0%	103,770	9/30/2021
2021 Q2	8/11/2021	1,146	0.0%	73,684	6/30/2021
2021 Q1	5/17/2021	866	0.0%	60,323	3/31/2021
2020 Q4	2/16/2021	1,101	0.0%	56,094	12/31/2020
2020 Q3	11/16/2020	521	0.0%	40,211	9/30/2020
2020 Q2	8/14/2020	498	0.0%	34,222	6/30/2020
2020 Q1	5/15/2020	271	0.0%	31,846	3/31/2020
2019 Q4	2/14/2020	385	0.0%	23,370	12/31/2019